Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anesthesia and Analgesia for Quality of Recovery in Radical Prostatectomy
NCT04587505Phase 4Completed
- Sponsor
- Clinical Hospital Center Split
- Start
- Apr 2019
- Primary completion
- Apr 2021
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ropivacaine hydrochloride liposomal suspension injection, morphine and tramadol in pain (2 arms), sponsored by Clinical Hospital Center Split. Primary endpoint: Quality of Recovery at 24 hours. Started Apr 2019; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injectionmorphinetramadol
03
Conditions
pain
Beyond the preview
Go deeper on NCT04587505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04587505.